...
首页> 外文期刊>American journal of respiratory and critical care medicine >Protective Role of Peroxisome Proliferator-activated Receptor-β/δ in Septic Shock
【24h】

Protective Role of Peroxisome Proliferator-activated Receptor-β/δ in Septic Shock

机译:过氧化物酶体增殖物激活受体-β/δ在感染性休克中的保护作用

获取原文
获取原文并翻译 | 示例

摘要

Rationale. Peroxisome proliferator-activated receptor (PPAR)-p/5 is a transcription factor that belongs to the PPAR nuclear hormone receptor family, but the role of PPAR-p/5 in sepsis is unknown. Objectives: We investigated the role of PPAR-p/5 in murine models of LPS-induced organ injury and dysfunction and cecal ligation and puncture (CLP)-induced polymicrobial sepsis. Methods: Wild-type (WT) and PPAR-p/5 knockout (KO) mice and C57BL/6 mice were subjected to LPS for 16 hours. C57BL/6 mice received the PPAR-P/8 agonist GW0742 (0.03 mg/kg intrave-nously, 1 h after LPS) or GW0742 plus the PPAR-p/5 antagonist GSK0660 (0.1 mg/kg intravenously, 30 min before LPS). CD-1 mice subjected to CLP received GW0742 or GW0742 plus GSK0660. Measurements and Main Results: In PPAR-p/8 KO mice, endotoxemia exacerbated organ injury and dysfunction (cardiac, renal, and hepatic) and inflammation (lung) compared with WT mice. In C57BL/6 mice subjected to endotoxemia, GW0742 significantly (7) attenuated organ (cardiac and renal) dysfunction and inflam-mation (lung); (2) increased the phosphorylation of Akt and glycogen synthase kinase (GSK)-3P; (3) attenuated the increase in extracellular signal-regulated kinase (ERK)1/2 and signal trans-ducer and activator of transcription (STAT)-3 phosphorylation; and (4) attenuated the activation of nuclear factor (NF)-kB and the expression of inducible nitric oxide synthase (iNOS). In CD-1 mice subjected to CLP, GW0742 improved 10-day survival. All the observed beneficial effects of GW0742 were attenuated by the PPAR-p/5 antagonist GSK0660. Conclusions: PPAR-P/8 protects against multiple organ injury and dysfunction, and inflammation caused by endotoxic shock and improves survival in polymicrobial sepsis by a mechanism that may involve activation of Akt and inhibition of GSK-3p and NF-kB.
机译:基本原理。过氧化物酶体增殖物激活受体(PPAR)-p / 5是一种转录因子,属于PPAR核激素受体家族,但PPAR-p / 5在败血症中的作用尚不清楚。目的:我们研究了PPAR-p / 5在LPS诱导的器官损伤和功能障碍以及盲肠结扎和穿刺(CLP)诱导的微生物败血症的小鼠模型中的作用。方法:对野生型(WT)和PPAR-p / 5基因敲除(KO)小鼠和C57BL / 6小鼠进行LPS处理16小时。 C57BL / 6小鼠接受PPAR-P / 8激动剂GW0742(LPS后1 h静脉内0.03 mg / kg)或GW0742加PPAR-p / 5拮抗剂GSK0660(LPS之前30min静脉内0.1 mg / kg) 。接受CLP的CD-1小鼠接受GW0742或GW0742加GSK0660。测量和主要结果:与WT小鼠相比,在PPAR-p / 8 KO小鼠中,内毒素血症加重了器官损伤和功能障碍(心脏,肾脏和肝脏)和炎症(肺)。在经历内毒素血症的C57BL / 6小鼠中,GW0742显着(7)减轻了器官(心脏和肾脏)功能障碍和炎症(肺); (2)增加了Akt和糖原合酶激酶(GSK)-3P的磷酸化; (3)减弱细胞外信号调节激酶(ERK)1/2和信号转导子及转录激活子(STAT)-3磷酸化的增加; (4)减弱了核因子(NF)-kB的激活和诱导型一氧化氮合酶(iNOS)的表达。在接受CLP的CD-1小鼠中,GW0742改善了10天生存期。 PPAR-p / 5拮抗剂GSK0660减弱了GW0742的所有观察到的有益作用。结论:PPAR-P / 8可通过涉及Akt活化和抑制GSK-3p和NF-kB的机制来预防多器官损伤和功能障碍以及内毒素性休克引起的炎症,并改善微生物败血症的存活率。

著录项

  • 来源
  • 作者单位

    Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, London, United Kingdom;

    Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, London, United Kingdom;

    Department of Anatomy,Pharmacology and Forensic Medicine, University of Turin, Turin, Italy;

    Ludwig Boltzmann Institute, Vienna, Austria;

    Ludwig Boltzmann Institute, Vienna, Austria;

    Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, London, United Kingdom;

    Pharmacology and Pharmacotoxicology Unit, Pharmacy School, University of Lisbon, Lisbon, Portugal;

    Department of Anatomy,Pharmacology and Forensic Medicine, University of Turin, Turin, Italy;

    Department of Anatomy,Pharmacology and Forensic Medicine, University of Turin, Turin, Italy;

    Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, London, United Kingdom;

    Pharmacology and Pharmacotoxicology Unit, Pharmacy School, University of Lisbon, Lisbon, Portugal;

    Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, London, United Kingdom;

    Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, London, United Kingdom;

    Ludwig Boltzmann Institute, Vienna, Austria;

    Center for Integrative Genomics, Lausanne, Switzerland;

    Cardiothoracic Pharmacology, National Heart and Lung Institute, London, United Kingdom;

    Queen Mary University of London, Barts and The London School of Medicine and Dentistry, William Harvey Research Institute,Centre for Translational Medicine and Therapeutics, Charterhouse Square,London, EC1M 6BQ, UK;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    GW0742; endotoxemia; polymicrobial sepsis; inflamma-tion; multiple organ injury and dysfunction;

    机译:GW0742;内毒素血症微生物败血症炎;多器官损伤和功能障碍;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号